Major Changes to Berkshire Hathaway’s Stock Portfolio During Third Quarter 2021

The following are the major changes made to Berkshire Hathaway’s stock portfolio during the third quarter of 2021.

New Positions:

(1) Royalty Pharma plc (+$475 million)

(2) Floor and Decor Holdings (+$100 million)

Addition to Positions:

(1) Chevron (+$560 million) (24% of stake)

Position Sold:

(1) Merck (-$750 million)

Position Reductions:

(1) Charter Communications (-$700 million) (19% of stake)

(2) AbbVie (-$600 million) (30% of stake)

(3) Bristol-Myers Squibb (-$250 million) (16% of stake)

(4) Marsh & McLennan (-$200 million) (35% of stake)

(5) U.S. Bancorp (-$150 million) (2% of stake)